Global Dog Vaccines Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Dog Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Dog Vaccines market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Dog Vaccines market include Zoetis (Pfizer), Merck Animal Health, Eli Lilly, Bayer Healthcare, Virbac, Vetoquinol S.A, Merial (Sanofi), Heska Co. and Ceva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Dog Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Dog Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Dog Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dog Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Dog Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Dog Vaccines sales, projected growth trends, production technology, application and end-user industry.
Dog Vaccines Segment by Company
Zoetis (Pfizer)
Merck Animal Health
Eli Lilly
Bayer Healthcare
Virbac
Vetoquinol S.A
Merial (Sanofi)
Heska Co.
Ceva
Boehringer Ingelheim
Dog Vaccines Segment by Type
Recombinant Vaccines
Subunit Vaccines
Inactivated Vaccines
Toxoid Vaccines
Attenuated Live Vaccines
Conjugate Vaccines
DNA Vaccines
Dog Vaccines Segment by Application
Below 6 Months
Above Months
Dog Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Dog Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Dog Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Dog Vaccines significant trends, drivers, influence factors in global and regions.
6. To analyze Dog Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dog Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dog Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dog Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Dog Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dog Vaccines industry.
Chapter 3: Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Dog Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Dog Vaccines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Dog Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Dog Vaccines market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Dog Vaccines market include Zoetis (Pfizer), Merck Animal Health, Eli Lilly, Bayer Healthcare, Virbac, Vetoquinol S.A, Merial (Sanofi), Heska Co. and Ceva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Dog Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Dog Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Dog Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dog Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Dog Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Dog Vaccines sales, projected growth trends, production technology, application and end-user industry.
Dog Vaccines Segment by Company
Zoetis (Pfizer)
Merck Animal Health
Eli Lilly
Bayer Healthcare
Virbac
Vetoquinol S.A
Merial (Sanofi)
Heska Co.
Ceva
Boehringer Ingelheim
Dog Vaccines Segment by Type
Recombinant Vaccines
Subunit Vaccines
Inactivated Vaccines
Toxoid Vaccines
Attenuated Live Vaccines
Conjugate Vaccines
DNA Vaccines
Dog Vaccines Segment by Application
Below 6 Months
Above Months
Dog Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Dog Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Dog Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Dog Vaccines significant trends, drivers, influence factors in global and regions.
6. To analyze Dog Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dog Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dog Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dog Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Dog Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dog Vaccines industry.
Chapter 3: Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Dog Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Dog Vaccines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
191 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Dog Vaccines Sales Value (2020-2031)
- 1.2.2 Global Dog Vaccines Sales Volume (2020-2031)
- 1.2.3 Global Dog Vaccines Sales Average Price (2020-2031)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Dog Vaccines Market Dynamics
- 2.1 Dog Vaccines Industry Trends
- 2.2 Dog Vaccines Industry Drivers
- 2.3 Dog Vaccines Industry Opportunities and Challenges
- 2.4 Dog Vaccines Industry Restraints
- 3 Dog Vaccines Market by Company
- 3.1 Global Dog Vaccines Company Revenue Ranking in 2024
- 3.2 Global Dog Vaccines Revenue by Company (2020-2025)
- 3.3 Global Dog Vaccines Sales Volume by Company (2020-2025)
- 3.4 Global Dog Vaccines Average Price by Company (2020-2025)
- 3.5 Global Dog Vaccines Company Ranking (2023-2025)
- 3.6 Global Dog Vaccines Company Manufacturing Base and Headquarters
- 3.7 Global Dog Vaccines Company Product Type and Application
- 3.8 Global Dog Vaccines Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Dog Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.9.3 2024 Dog Vaccines Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
- 4 Dog Vaccines Market by Type
- 4.1 Dog Vaccines Type Introduction
- 4.1.1 Recombinant Vaccines
- 4.1.2 Subunit Vaccines
- 4.1.3 Inactivated Vaccines
- 4.1.4 Toxoid Vaccines
- 4.1.5 Attenuated Live Vaccines
- 4.1.6 Conjugate Vaccines
- 4.1.7 DNA Vaccines
- 4.2 Global Dog Vaccines Sales Volume by Type
- 4.2.1 Global Dog Vaccines Sales Volume by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Dog Vaccines Sales Volume by Type (2020-2031)
- 4.2.3 Global Dog Vaccines Sales Volume Share by Type (2020-2031)
- 4.3 Global Dog Vaccines Sales Value by Type
- 4.3.1 Global Dog Vaccines Sales Value by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Dog Vaccines Sales Value by Type (2020-2031)
- 4.3.3 Global Dog Vaccines Sales Value Share by Type (2020-2031)
- 5 Dog Vaccines Market by Application
- 5.1 Dog Vaccines Application Introduction
- 5.1.1 Below 6 Months
- 5.1.2 Above Months
- 5.2 Global Dog Vaccines Sales Volume by Application
- 5.2.1 Global Dog Vaccines Sales Volume by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Dog Vaccines Sales Volume by Application (2020-2031)
- 5.2.3 Global Dog Vaccines Sales Volume Share by Application (2020-2031)
- 5.3 Global Dog Vaccines Sales Value by Application
- 5.3.1 Global Dog Vaccines Sales Value by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Dog Vaccines Sales Value by Application (2020-2031)
- 5.3.3 Global Dog Vaccines Sales Value Share by Application (2020-2031)
- 6 Dog Vaccines Regional Sales and Value Analysis
- 6.1 Global Dog Vaccines Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Dog Vaccines Sales by Region (2020-2031)
- 6.2.1 Global Dog Vaccines Sales by Region: 2020-2025
- 6.2.2 Global Dog Vaccines Sales by Region (2026-2031)
- 6.3 Global Dog Vaccines Sales Value by Region: 2020 VS 2024 VS 2031
- 6.4 Global Dog Vaccines Sales Value by Region (2020-2031)
- 6.4.1 Global Dog Vaccines Sales Value by Region: 2020-2025
- 6.4.2 Global Dog Vaccines Sales Value by Region (2026-2031)
- 6.5 Global Dog Vaccines Market Price Analysis by Region (2020-2025)
- 6.6 North America
- 6.6.1 North America Dog Vaccines Sales Value (2020-2031)
- 6.6.2 North America Dog Vaccines Sales Value Share by Country, 2024 VS 2031
- 6.7 Europe
- 6.7.1 Europe Dog Vaccines Sales Value (2020-2031)
- 6.7.2 Europe Dog Vaccines Sales Value Share by Country, 2024 VS 2031
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Dog Vaccines Sales Value (2020-2031)
- 6.8.2 Asia-Pacific Dog Vaccines Sales Value Share by Country, 2024 VS 2031
- 6.9 South America
- 6.9.1 South America Dog Vaccines Sales Value (2020-2031)
- 6.9.2 South America Dog Vaccines Sales Value Share by Country, 2024 VS 2031
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Dog Vaccines Sales Value (2020-2031)
- 6.10.2 Middle East & Africa Dog Vaccines Sales Value Share by Country, 2024 VS 2031
- 7 Dog Vaccines Country-level Sales and Value Analysis
- 7.1 Global Dog Vaccines Sales by Country: 2020 VS 2024 VS 2031
- 7.2 Global Dog Vaccines Sales Value by Country: 2020 VS 2024 VS 2031
- 7.3 Global Dog Vaccines Sales by Country (2020-2031)
- 7.3.1 Global Dog Vaccines Sales by Country (2020-2025)
- 7.3.2 Global Dog Vaccines Sales by Country (2026-2031)
- 7.4 Global Dog Vaccines Sales Value by Country (2020-2031)
- 7.4.1 Global Dog Vaccines Sales Value by Country (2020-2025)
- 7.4.2 Global Dog Vaccines Sales Value by Country (2026-2031)
- 7.5 USA
- 7.5.1 USA Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.5.2 USA Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.5.3 USA Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.6 Canada
- 7.6.1 Canada Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.6.2 Canada Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Canada Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.7 Mexico
- 7.6.1 Mexico Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.6.2 Mexico Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Mexico Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.8 Germany
- 7.8.1 Germany Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.8.2 Germany Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.8.3 Germany Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.9 France
- 7.9.1 France Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.9.2 France Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.9.3 France Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.10 U.K.
- 7.10.1 U.K. Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.10.2 U.K. Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.10.3 U.K. Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.11 Italy
- 7.11.1 Italy Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.11.2 Italy Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Italy Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.12 Spain
- 7.12.1 Spain Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.12.2 Spain Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Spain Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.13 Russia
- 7.13.1 Russia Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.13.2 Russia Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Russia Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.14 Netherlands
- 7.14.1 Netherlands Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.14.2 Netherlands Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.14.3 Netherlands Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.15.2 Nordic Countries Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Nordic Countries Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.16 China
- 7.16.1 China Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.16.2 China Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.16.3 China Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.17 Japan
- 7.17.1 Japan Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.17.2 Japan Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.17.3 Japan Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.18 South Korea
- 7.18.1 South Korea Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.18.2 South Korea Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.18.3 South Korea Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.19 India
- 7.19.1 India Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.19.2 India Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.19.3 India Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.20 Australia
- 7.20.1 Australia Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.20.2 Australia Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Australia Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.21.2 Southeast Asia Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Southeast Asia Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.22 Brazil
- 7.22.1 Brazil Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.22.2 Brazil Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Brazil Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.23 Argentina
- 7.23.1 Argentina Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.23.2 Argentina Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Argentina Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.24 Chile
- 7.24.1 Chile Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.24.2 Chile Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Chile Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.25 Colombia
- 7.25.1 Colombia Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.25.2 Colombia Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Colombia Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.26 Peru
- 7.26.1 Peru Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.26.2 Peru Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Peru Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.27.2 Saudi Arabia Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.27.3 Saudi Arabia Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.28 Israel
- 7.28.1 Israel Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.28.2 Israel Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Israel Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.29 UAE
- 7.29.1 UAE Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.29.2 UAE Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.29.3 UAE Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.30 Turkey
- 7.30.1 Turkey Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.30.2 Turkey Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Turkey Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.31 Iran
- 7.31.1 Iran Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.31.2 Iran Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.31.3 Iran Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.32 Egypt
- 7.32.1 Egypt Dog Vaccines Sales Value Growth Rate (2020-2031)
- 7.32.2 Egypt Dog Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.32.3 Egypt Dog Vaccines Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Zoetis (Pfizer)
- 8.1.1 Zoetis (Pfizer) Comapny Information
- 8.1.2 Zoetis (Pfizer) Business Overview
- 8.1.3 Zoetis (Pfizer) Dog Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.1.4 Zoetis (Pfizer) Dog Vaccines Product Portfolio
- 8.1.5 Zoetis (Pfizer) Recent Developments
- 8.2 Merck Animal Health
- 8.2.1 Merck Animal Health Comapny Information
- 8.2.2 Merck Animal Health Business Overview
- 8.2.3 Merck Animal Health Dog Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.2.4 Merck Animal Health Dog Vaccines Product Portfolio
- 8.2.5 Merck Animal Health Recent Developments
- 8.3 Eli Lilly
- 8.3.1 Eli Lilly Comapny Information
- 8.3.2 Eli Lilly Business Overview
- 8.3.3 Eli Lilly Dog Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.3.4 Eli Lilly Dog Vaccines Product Portfolio
- 8.3.5 Eli Lilly Recent Developments
- 8.4 Bayer Healthcare
- 8.4.1 Bayer Healthcare Comapny Information
- 8.4.2 Bayer Healthcare Business Overview
- 8.4.3 Bayer Healthcare Dog Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.4.4 Bayer Healthcare Dog Vaccines Product Portfolio
- 8.4.5 Bayer Healthcare Recent Developments
- 8.5 Virbac
- 8.5.1 Virbac Comapny Information
- 8.5.2 Virbac Business Overview
- 8.5.3 Virbac Dog Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.5.4 Virbac Dog Vaccines Product Portfolio
- 8.5.5 Virbac Recent Developments
- 8.6 Vetoquinol S.A
- 8.6.1 Vetoquinol S.A Comapny Information
- 8.6.2 Vetoquinol S.A Business Overview
- 8.6.3 Vetoquinol S.A Dog Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.6.4 Vetoquinol S.A Dog Vaccines Product Portfolio
- 8.6.5 Vetoquinol S.A Recent Developments
- 8.7 Merial (Sanofi)
- 8.7.1 Merial (Sanofi) Comapny Information
- 8.7.2 Merial (Sanofi) Business Overview
- 8.7.3 Merial (Sanofi) Dog Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.7.4 Merial (Sanofi) Dog Vaccines Product Portfolio
- 8.7.5 Merial (Sanofi) Recent Developments
- 8.8 Heska Co.
- 8.8.1 Heska Co. Comapny Information
- 8.8.2 Heska Co. Business Overview
- 8.8.3 Heska Co. Dog Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.8.4 Heska Co. Dog Vaccines Product Portfolio
- 8.8.5 Heska Co. Recent Developments
- 8.9 Ceva
- 8.9.1 Ceva Comapny Information
- 8.9.2 Ceva Business Overview
- 8.9.3 Ceva Dog Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.9.4 Ceva Dog Vaccines Product Portfolio
- 8.9.5 Ceva Recent Developments
- 8.10 Boehringer Ingelheim
- 8.10.1 Boehringer Ingelheim Comapny Information
- 8.10.2 Boehringer Ingelheim Business Overview
- 8.10.3 Boehringer Ingelheim Dog Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.10.4 Boehringer Ingelheim Dog Vaccines Product Portfolio
- 8.10.5 Boehringer Ingelheim Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Dog Vaccines Value Chain Analysis
- 9.1.1 Dog Vaccines Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Dog Vaccines Sales Mode & Process
- 9.2 Dog Vaccines Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Dog Vaccines Distributors
- 9.2.3 Dog Vaccines Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


